[Risedronate now also approved for hip fractures. Study discloses significant risk reduction in proximal femoral neck fractures].
D000368:Aged; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D005265:Femoral Neck Fractures / Q000188:drug therapy*; D005598:Fractures, Spontaneous / Q000188:drug therapy*; D005858:Germany; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D000068296:Risedronic Acid; D012307:Risk Factors
D000068296:Risedronic Acid; D012968:Etidronic Acid